Hallmarks of cancer: the next generation - PubMed (original) (raw)
Review
. 2011 Mar 4;144(5):646-74.
doi: 10.1016/j.cell.2011.02.013.
Affiliations
- PMID: 21376230
- DOI: 10.1016/j.cell.2011.02.013
Free article
Review
Hallmarks of cancer: the next generation
Douglas Hanahan et al. Cell. 2011.
Free article
Abstract
The hallmarks of cancer comprise six biological capabilities acquired during the multistep development of human tumors. The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease. They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis. Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions. Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metabolism and evading immune destruction. In addition to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment." Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.
Copyright © 2011 Elsevier Inc. All rights reserved.
Similar articles
- Rho GTPases modulate malignant transformation of tumor cells.
Orgaz JL, Herraiz C, Sanz-Moreno V. Orgaz JL, et al. Small GTPases. 2014;5:e29019. doi: 10.4161/sgtp.29019. Epub 2014 May 8. Small GTPases. 2014. PMID: 25036871 Free PMC article. Review. - The contribution of tumour-derived exosomes to the hallmarks of cancer.
Meehan K, Vella LJ. Meehan K, et al. Crit Rev Clin Lab Sci. 2016;53(2):121-31. doi: 10.3109/10408363.2015.1092496. Epub 2015 Oct 19. Crit Rev Clin Lab Sci. 2016. PMID: 26479834 Review. - Hallmarks of Cancers: Primary Antibody Deficiency Versus Other Inborn Errors of Immunity.
Abolhassani H, Wang Y, Hammarström L, Pan-Hammarström Q. Abolhassani H, et al. Front Immunol. 2021 Aug 17;12:720025. doi: 10.3389/fimmu.2021.720025. eCollection 2021. Front Immunol. 2021. PMID: 34484227 Free PMC article. Review. - Tumor-stroma crosstalk: targeting stroma in breast cancer.
Criscitiello C, Esposito A, Curigliano G. Criscitiello C, et al. Curr Opin Oncol. 2014 Nov;26(6):551-5. doi: 10.1097/CCO.0000000000000122. Curr Opin Oncol. 2014. PMID: 25279962 Review. - Long non-coding RNAs in cancer: Another layer of complexity.
de Oliveira JC, Oliveira LC, Mathias C, Pedroso GA, Lemos DS, Salviano-Silva A, Jucoski TS, Lobo-Alves SC, Zambalde EP, Cipolla GA, Gradia DF. de Oliveira JC, et al. J Gene Med. 2019 Jan;21(1):e3065. doi: 10.1002/jgm.3065. Epub 2019 Jan 8. J Gene Med. 2019. PMID: 30549380 Review.
Cited by
- An insight into the role of innate immune cells in breast tumor microenvironment.
Garg S, Rai G, Singh S, Gauba P, Ali J, Dang S. Garg S, et al. Breast Cancer. 2025 Jan;32(1):79-100. doi: 10.1007/s12282-024-01645-8. Epub 2024 Oct 26. Breast Cancer. 2025. PMID: 39460874 Review. - Hepatocellular-Carcinoma-Derived Organoids: Innovation in Cancer Research.
Airola C, Pallozzi M, Cesari E, Cerrito L, Stella L, Sette C, Giuliante F, Gasbarrini A, Ponziani FR. Airola C, et al. Cells. 2024 Oct 18;13(20):1726. doi: 10.3390/cells13201726. Cells. 2024. PMID: 39451244 Free PMC article. Review. - HSPD1 Supports Osteosarcoma Progression through Stabilizing ATP5A1 and thus Activation of AKT/mTOR Signaling.
Zhang Y, Pan R, Li K, Cheang LH, Zhao J, Zhong Z, Li S, Wang J, Zhang X, Cheng Y, Zheng X, He R, Wang H. Zhang Y, et al. Int J Biol Sci. 2024 Sep 23;20(13):5162-5190. doi: 10.7150/ijbs.100015. eCollection 2024. Int J Biol Sci. 2024. PMID: 39430254 Free PMC article. - Oncolytic virotherapy against lung cancer: key receptors and signaling pathways of viral entry.
Dong W, Luo Y, He D, Zhang M, Zeng J, Chen Y. Dong W, et al. Front Immunol. 2024 Oct 4;15:1473288. doi: 10.3389/fimmu.2024.1473288. eCollection 2024. Front Immunol. 2024. PMID: 39430750 Free PMC article. Review. - Assessing the Prognostic Value of 13 Inflammation-Based Scores in Patients with Unresectable or Advanced Biliary Tract Carcinoma After Immunotherapy.
Wang F, Jiang C, He W, Li H, Guo GF, Xu L. Wang F, et al. Immunotargets Ther. 2024 Oct 16;13:541-557. doi: 10.2147/ITT.S471502. eCollection 2024. Immunotargets Ther. 2024. PMID: 39431245 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases